Florida Hospital uses flexible surgery instruments from Apollo Endosurgery for stomach tumor extraction

NewsGuard 100/100 Score

Florida Hospital Celebration Health announced this week the use of a new class of flexible surgical instruments created by Apollo Endosurgery®, to remove a stomach tumor and extract it through the patient's mouth. Following the two-hour surgery, the patient spent one night in the hospital and was prescribed Acetaminophen for pain. This is a stark contrast to minimally invasive or open surgeries which necessitate incisions and can require anywhere  from two to eight weeks of recovery time.

"Revolutionary cases like this one begin to reveal the potential of new flexible surgery techniques and tools designed to remove early stage lesions from the colon, esophagus, and stomach," says Jay Redan, MD, Medical Director of Minimally Invasive Surgery at Florida Hospital Celebration Health.

Development of flexible surgical instruments like the one used at Florida Hospital could not have been possible without the support and generous funding from the Cancer Prevention Research Institute of Texas (CPRIT). Dennis McWilliams, CEO and President for Apollo Endosurgery®, says, "Apollo Endosurgery is honored to be among the first of three companies in Texas to have received a commercialization grant from CPRIT. We've used these funds to advance therapeutic flexible endoscopy and other less invasive therapies. We're excited to see the application of our tools in the endoluminal removal of lesions from the stomach."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease